comparemela.com
Home
Live Updates
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference : comparemela.com
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual
Related Keywords
Canada ,
Brazil ,
Brazilian ,
Arlene Padron ,
Jill Fiedler Kelly ,
Shawn Oconnor ,
Rajanikanth Madabushi ,
Simulations Plus Resource Center ,
Drug Administration ,
Simulations Plus Inc ,
Nasdaq ,
Drug Development ,
Exchange Commission ,
Youtube ,
Office Of Clinical Pharmacology ,
Health Canada ,
Simulations Plus ,
Scientific Conference ,
Associate Director ,
Scientific Policy ,
Clinical Pharmacology ,
Model Informed Drug Development ,
Integrative Approach ,
United Kingdom ,
Divisional President ,
Simulations Plus Resource ,
Harbor Statement Under ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.